Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.
Why do not all living kidney donor candidates proceed to donation?
Cash, E; Graver, A; Kuo, S; Kirkland, G; Hughes, P; Robertson, A; Jose, MD
(2019), INTERNAL MEDICINE JOURNAL, 384-387
DOI: 10.1111/imj.14223
Outcomes of cinacalcet withdrawal in Australian dialysis patients
Ruderman, I; Holt, SG; Kirkland, GS; Maslen, S; Hawley, CM; Oliver, V; Krishnasamy, R; Gray, NA; Talaulikar, GS; Nelson, CL; Rajaram, Y; Gock, H; Au, E; Elder, GJ; Mainra, R; Toussaint, ND
(2019), INTERNAL MEDICINE JOURNAL, 48-54
DOI: 10.1111/imj.14036
Optimizing Mycophenolic Acid Exposure in Kidney Transplant Recipients: Time for Target Concentration Intervention
Metz, DK; Holford, N; Kausman, JY; Walker, A; Cranswick, N; Staatz, CE; Barraclough, KA; Ierino, F
(2019), TRANSPLANTATION, 2012-2030
Examining the Increased Rates of Deceased Donor Kidney Nonutilization in Australia: What Has Changed?
Sypek, MP; Ullah, S; Hughes, PD; Clayton, PA; McDonald, SP
(2019), TRANSPLANTATION, 2582-2590
External validation of the US and UK kidney donor risk indices for deceased donor kidney transplant survival in the Australian and New Zealand population
Clayton, PA; Dansie, K; Sypek, MP; White, S; Chadban, S; Kanellis, J; Hughes, P; Gulyani, A; McDonald, S
(2019), NEPHROLOGY DIALYSIS TRANSPLANTATION, 2127-2131
DOI: 10.1093/ndt/gfz090
Diagnostic Tests for Vascular Calcification
Smith, ER; Hewitson, TD; Holt, SG
(2019), ADVANCES IN CHRONIC KIDNEY DISEASE, 445-463
Improving medication adherence in adult kidney transplantation (IMAKT): A pilot randomised controlled trial
Low, JK; Manias, E; Crawford, K; Walker, R; Mulley, WR; Toussaint, ND; Dooley, M; Kennedy, E; Smith, CL; Nalder, M; Yip, D; Williams, A
(2019), SCIENTIFIC REPORTS
Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study
Germain, DP; Nicholls, K; Giugliani, R; Bichet, DG; Hughes, DA; Barisoni, LM; Colvin, RB; Jennette, JC; Skuban, N; Castelli, JP; Benjamin, E; Barth, JA; Viereck, C
(2019), GENETICS IN MEDICINE, 1987-1997
Pre-analytical stability of FGF23 with the contemporary immunoassays
Dirks, NF; Smith, ER; van Schoor, NM; Vervloet, MG; Ackermans, MT; de Jonge, R; Heijboer, AC
(2019), CLINICA CHIMICA ACTA, 104-106
The Fibrosis Across Organs Symposium: A Roadmap for Future Research Priorities
Roman, J; Barnes, TR; Kervitsky, DJ; Cosgrove, GP; Doherty, DE; Tager, AM; Richeldi, L; White, ES; Brenner, DA; Schnapp, LM; Hewitson, TD; Jugdutt, BI; McKinsey, TA; Tosi, JD; Crane, S; Brown, KK
(2019), AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 405-410
Home haemodialysis: how it began, where it went wrong, and what it may yet be
Agar, JWM; Barraclough, KA; Piccoli, GB
(2019), JOURNAL OF NEPHROLOGY, 331-333
Nephrology in the global environment
Agar, JWM; Barraclough, KA; Piccoli, GB
(2019), JOURNAL OF NEPHROLOGY, 163-164
Association of Handgrip Strength and Muscle Mass with Dependency in (Instrumental) Activities of Daily Living in Hospitalized Older Adults -The EMPOWER Study
Meskers, CGM; Reijnierse, EM; Numans, ST; Kruizinga, RC; Pierik, VD; Van Ancum, JM; Slee-Valentijn, M; Scheerman, K; Verlaan, S; Maier, AB
(2019), JOURNAL OF NUTRITION HEALTH & AGING, 232-238
alpha Klotho-FGF23 interactions and their role in kidney disease: a molecular insight
Smith, ER; Holt, SG; Hewitson, TD
(2019), CELLULAR AND MOLECULAR LIFE SCIENCES, 4705-4724
Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial
Schiffmann, R; Goker-Alpan, O; Holida, M; Giraldo, P; Barisoni, L; Colvin, RB; Jennette, CJ; Maegawa, G; Boyadjiev, SA; Gonzalez, D; Nicholls, K; Tuffaha, A; Atta, MG; Rup, B; Charney, MR; Paz, A; Szlaifer, M; Alon, S; Brill-Almon, E; Chertkoff, R; Hughes, D
(2019), JOURNAL OF INHERITED METABOLIC DISEASE, 534-544
DOI: 10.1002/jimd.12080
Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study
Hughes, DA; Nicholls, K; Sunder-Plassmann, G; Jovanovic, A; Feldt-Rasmussen, U; Schiffmann, R; Giugliani, R; Jain, V; Viereck, C; Castelli, JP; Skuban, N; Barth, JA; Bichet, DG
(2019), AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 1069-1073
DOI: 10.1002/ajmg.a.61105
Comparison of graft and patient outcomes following kidney transplantation in extended hour and conventional haemodialysis patients
See, EJ; Hawley, CM; Cho, Y; Toussaint, ND; Agar, JWM; Pascoe, EM; Lim, WH; Francis, RS; Collins, MG; Johnson, DW
(2019), Nephrology, 111-120
DOI: 10.1111/nep.13221
Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure
See, EJ; Jayasinghe, K; Glassford, N; Bailey, M; Johnson, DW; Polkinghorne, KR; Toussaint, ND; Bellomo, R
(2019), Kidney Int., 160-172
Quantifying the medication burden of kidney transplant recipients in the first year post-transplantation
Low, JK; Crawford, K; Manias, E; Williams, A
(2018), Int. J. Clin. Phar,., 1242-1249
De novo or early conversion to everolimus and long-term cancer outcomes in kidney transplant recipients: A trial-based linkage study
Ying, T; Wong, G; Lim, W; Kanellis, J; Pilmore, H; Campbell, S; Masterson, R; Walker, R; O'Connell, P; Russ, G; Chadban, S
(2018), Am. J. Transplant., 2977-2986
DOI: 10.1111/ajt.14948
Improvement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry Registry
Wilcox, WR; Feldt-Rasmussen, U; Martins, AM; Ortiz, A; Lemay, RM; Jovanovic, A; Germain, DP; Varas, C; Nicholls, K; Weidemann, F; Hopkin, RJ
(2018), 45-51
DOI: 10.1007/8904_2017_28
Clinical quality registries for clinician-level reporting: strengths and limitations
Sypek, MP; Jose, MD; McDonald, SP
(2018), Med. J. Aust.
DOI: 10.5694/mja17.00581
HLA Epitope Matching in Kidney Transplantation: An Overview for the General Nephrologist
Sypek, M; Kausman, J; Holt, S; Hughes, P
(2018), Am. J. Kidney Dis., 720-731
Migalastat for the treatment of Fabry disease
Sunder-Plassmann, G; Schiffmann, R; Nicholls, K
(2018), Exp. Opin. Orphan Drugs, 301-309
Biochemical transformation of calciprotein particles in uraemia
Smith, ER; Hewitson, TD; Hanssen, E; Holt, SG
(2018), Bone, 355-367
Untangling the thread of life spun by alpha Klotho
Smith, ER
(2018), J. Mol. Med., 857-859
Delayed myelination and neurodevelopment in male seizure-prone versus seizure-resistant rats
Sharma, P; Powell, KL; Wlodek, ME; O'Brien, TJ; Gilby, KL
(2018), Epilepsia, 753-764
DOI: 10.1111/epi.14013
Deterioration of Cortical Bone Microarchitecture: Critical Component of Renal Osteodystrophy Evaluation
Sharma, AK; Toussaint, ND; Masterson, R; Hoit, SG; Rajapakse, CS; Ebeling, PR; Mohanty, ST; Baldock, P; Elder, GJ
(2018), Am. J. Nephrol., 376-384
DOI: 10.1159/000489671
Changes in bone microarchitecture following kidney transplantation-Beyond bone mineral density
Sharma, AK; Toussaint, ND; Elder, GJ; Rajapakse, CS; Holt, SG; Baldock, P; Robertson, PL; Ebeling, PR; Sorci, OR; Masterson, R
(2018), Clin. Transplant.
DOI: 10.1111/ctr.13347
Magnetic resonance imaging based assessment of bone microstructure as a non-invasive alternative to histomorphometry in patients with chronic kidney disease
Sharma, AK; Toussaint, ND; Elder, GJ; Masterson, R; Holt, SG; Robertson, PL; Ebeling, PR; Baldock, P; Miller, RC; Rajapakse, CS
(2018), Bone, 14-21